"Crying Fire in a Theater" or a "Confirmatory Sighting?"**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 50, Issue 3, 2007, Pages 268-269

  Ellis, Stephen G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

DRUG ELUTING STENT; EDITORIAL; HEART ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; PRIORITY JOURNAL; RESTENOSIS; SUDDEN DEATH; THROMBOSIS; VEIN GRAFT DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALS; PROSTHESIS DESIGN; RISK ASSESSMENT; SIROLIMUS; STENTS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34447125025     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.05.011     Document Type: Editorial

References (13)

1. Vermeersch P., Agostoni P., Verheye S., et al., DELAYED RRISC Investigators. Increased late mortality after sirolimus-eluting stents versus bare metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC trial. J Am Coll Cardiol 50 (2007) 261-267
2. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al., BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
3. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., Wallentin L., and SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
4. Daemen J., Wenaweser P., Tsuchida K., et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369 (2007) 667-678
5. Stone G.W., Moses J.W., Ellis S.G., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
6. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
7. Steffel J., Latini R.A., Akhmedov A., et al. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design. Circulation 13 (2005) 2002-2011
8. Salloum J., Tharpe C., Vaughan D., and Zhao D.X. Release and elimination of soluble vasoactive factors during percutaneous coronary interventional of saphenous vein grafts: analysis using the PercuSurge GuardWire distal protection device. J Intervent Cardiol 17 (2005) 575-579
9. Meier P., Zbinden R., Togni M., Wenaweser P., Windecker S., Meier B., and Seiler C. Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol 40 (2007) 21-22
10. Vermeersch P., Agostoni P., Verheye S., et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial. J Am Coll Cardiol 48 (2006) 2423-2431
11. Ge L., Iakovou I., Sangiorgi G.M., et al. Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome. J Am Coll Cardiol 45 (2005) 980-994
12. Price M.J., Sawhney N., Kao J.A., Madrid A., Schatz R.A., and Teirstein P.S. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions. Catheter Cardiovasc Intervent 65 (2005) 208-211
13. Ellis S.G., Kent K., Raizner A.E., et al. TCT-1 year results from the TAXUS-V ISR trial: a randomized trial of paclitaxel-eluting coronary stents versus vascular brachytherapy for treatment of restenosis in bare metal stents. Am J Cardiol 98 (2006) 143M